Carolina’s $24.8M moonshot to stop Alzheimer’s, pulmonary fibrosis from the start
IMPEDE, a seven-institution team led by UNC-Chapel Hill with industry partner Siemens Healthineers, aims to deliver an FDA-ready early-detection biomarker and preclinical treatments for Alzheimer’s disease and pulmonary fibrosis in just four years.
Read more


